This blog analyzes Vonoprazan Fumarate API Market Trends, covering emerging therapies, technological advancements, and patient-focused innovations driving growth.
The market trends indicate a clear shift from conventional PPIs to potassium-competitive acid blockers like Vonoprazan, due to their faster onset and sustained acid suppression. Patients with GERD, peptic ulcers, and H. pylori...